GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » US Physical Therapy Inc (FRA:UPH) » Definitions » Research & Development

US Physical Therapy (FRA:UPH) Research & Development : €0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is US Physical Therapy Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. US Physical Therapy's Research & Development for the three months ended in Mar. 2024 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was €0.0 Mil.


US Physical Therapy Research & Development Historical Data

The historical data trend for US Physical Therapy's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

US Physical Therapy Research & Development Chart

US Physical Therapy Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

US Physical Therapy Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

US Physical Therapy Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


US Physical Therapy  (FRA:UPH) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


US Physical Therapy Research & Development Related Terms

Thank you for viewing the detailed overview of US Physical Therapy's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


US Physical Therapy (FRA:UPH) Business Description

Traded in Other Exchanges
Address
1300 West Sam Houston Parkway South, Suite 300, Houston, TX, USA, 77042
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal sources of payment for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.

US Physical Therapy (FRA:UPH) Headlines

No Headlines